register

Marketing & Strategy

Bayer, MSD and Takeda among winners at Asia Pacific awards

Health Industry Hub | March 28, 2024 |

Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations that have pushed boundaries in patient care, leaving a lasting impact on their local communities.

Among the standout accomplishments at the Healthcare Asia Pharma Awards, Bayer Singapore claimed top honours for both the Digital Innovation of the Year and the Marketing & Communications Initiative of the Year categories. Their Bayer For Her campaign captured hearts and minds, igniting a crucial conversation about women’s health across Asia.

At the core of the campaign lies a simple yet powerful concept: providing a safe space for women to voice their health concerns. Through a user-friendly QR code interface, women can seamlessly connect with local healthcare professionals who offer tailored guidance and support. Initially launched in Thailand in September 2022, Bayer For Her has rapidly expanded its footprint, now spanning nine Asian countries and collaborating with 18 local partners and non-governmental organizations.

The campaign’s success is underscored by its multifaceted approach, leveraging strategic partnerships and innovative tactics to reach diverse audiences. From educational events and pharmacy collaborations to pop-up clinics and digital outreach efforts, Bayer left no stone unturned in its mission to empower women and promote health awareness.

Notably, the campaign’s digital activation on social media platforms like Instagram, Meta, TikTok, and KakaoTalk resonated deeply, garnered 692 million impressions. Additionally, Bayer’s commitment to community engagement shines through the campaign’s mobilisation of employees and healthcare professionals, with the latter providing free consultations in some markets.

Other industry leaders including MSD, Takeda, Alcon and Cipla were also recognised for their exemplary efforts. MSD Australia and MSD Singapore clinched awards for their outstanding Marketing & Communications Initiative and Patient Advocacy Program, respectively. Meanwhile, Takeda emerged victorious in several categories across its Singapore, Thailand and Taiwan affiliates.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.